← Back to guidelines
Ophthalmology11 papers

Hallermann-Streiff syndrome

Last edited: 4/14/2026

Overview

Hallermann-Streiff syndrome (HSS) is a rare genetic disorder characterized by distinctive craniofacial features, ocular abnormalities including congenital cataracts and microphthalmia, and systemic manifestations such as skin atrophy and dental anomalies 3.

Diagnosis

  • Key Diagnostic Criteria:
  • - Craniofacial dysostosis (including micrognathia, beaked nose, and malar hypoplasia) 3 - Ocular anomalies (congenital cataracts, microphthalmia, and sometimes retinal dystrophy) 3 - Skin changes (atrophy, dryness, and hyperkeratosis) 3 - Dental abnormalities (small teeth, delayed eruption) 3 - Growth retardation and developmental delay 3
  • Recommended Tests:
  • - Ophthalmic examination for cataracts and retinal assessment 3 - Radiographic imaging (X-rays) to evaluate craniofacial structure 3 - Genetic testing for chromosomal abnormalities (e.g., 4q deficiency/14q duplication) 2

    Management

  • First-Line Treatments:
  • - Early surgical intervention for bilateral cataracts to preserve vision 5 - Custom postcataract contact lenses for optimal ocular rehabilitation 5
  • Adjunctive Treatments:
  • - Regular ophthalmologic follow-ups to monitor ocular health 5 - Multidisciplinary care including dermatology, dentistry, and physical therapy 3 - Nutritional support and growth monitoring due to growth retardation 3

    Special Populations

  • Pediatrics:
  • - Early surgical intervention for cataracts is crucial to prevent visual impairment 5 - Comprehensive developmental support and monitoring 3
  • Comorbidities:
  • - Hemihypertrophy has been reported in association with HSS, though uncommon 1 - Genetic abnormalities like 4q deficiency/14q duplication may require specific genetic counseling 2

    Key Recommendations

  • Perform early ophthalmologic evaluation and surgical intervention for cataracts to prevent visual impairment (Evidence: Moderate 5)
  • Implement multidisciplinary care addressing craniofacial, ocular, dental, and systemic issues (Evidence: Expert opinion 3)
  • Consider genetic testing for chromosomal abnormalities in cases with atypical presentations (Evidence: Weak 2)
  • References

    1 Dogan DG, Karabiber H, Erhan MD, Garipardic M, Davutoglu M, Guler E. Hallermann-Streiff syndrome with hemihypertrophy. Genetic counseling (Geneva, Switzerland) 2010. link 2 Fryns JP, Borghgraef M, Lemmens F, van den Berghe H. MCA/MR syndrome with features of Hallermann-Streiff syndrome and 4q deficiency/14q duplication. Clinical genetics 1993. link 3 De Wilde GA, Meire FM. The Hallermann-Streiff syndrome. Bulletin de la Societe belge d'ophtalmologie 1991. link 4 van Balen AT. François' syndrome. An intermediate between mandibulofacial and craniofacial dysostoses. Ophthalmic paediatrics and genetics 1985. link 5 Ronen S, Rozenmann Y, Isaacson M, Amit M, Bier N. The early management of baby with Hallermann-Steriff-Francois Syndrome. Journal of pediatric ophthalmology and strabismus 1979. link

    Original source

    1. [1]
      Hallermann-Streiff syndrome with hemihypertrophy.Dogan DG, Karabiber H, Erhan MD, Garipardic M, Davutoglu M, Guler E Genetic counseling (Geneva, Switzerland) (2010)
    2. [2]
      MCA/MR syndrome with features of Hallermann-Streiff syndrome and 4q deficiency/14q duplication.Fryns JP, Borghgraef M, Lemmens F, van den Berghe H Clinical genetics (1993)
    3. [3]
      The Hallermann-Streiff syndrome.De Wilde GA, Meire FM Bulletin de la Societe belge d'ophtalmologie (1991)
    4. [4]
      François' syndrome. An intermediate between mandibulofacial and craniofacial dysostoses.van Balen AT Ophthalmic paediatrics and genetics (1985)
    5. [5]
      The early management of baby with Hallermann-Steriff-Francois Syndrome.Ronen S, Rozenmann Y, Isaacson M, Amit M, Bier N Journal of pediatric ophthalmology and strabismus (1979)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG